These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

783 related items for PubMed ID: 17709149

  • 1. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
    Guerrero Urbano T, Clark CH, Hansen VN, Adams EJ, A'Hern R, Miles EA, McNair H, Bidmead M, Warrington AP, Dearnaley DP, Harrington KJ, Nutting CM.
    Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
    [Abstract] [Full Text] [Related]

  • 2. Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I study.
    Urbano TG, Clark CH, Hansen VN, Adams EJ, Miles EA, Mc Nair H, Bidmead AM, Warrington J, Dearnaley DP, Harmer C, Harrington KJ, Nutting CM.
    Radiother Oncol; 2007 Oct; 85(1):58-63. PubMed ID: 17904235
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569
    [Abstract] [Full Text] [Related]

  • 4. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
    Klem ML, Mechalakos JG, Wolden SL, Zelefsky MJ, Singh B, Kraus D, Shaha A, Shah J, Pfister DG, Lee NY.
    Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):1100-7. PubMed ID: 17980501
    [Abstract] [Full Text] [Related]

  • 5. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF, Puri DR, Zhung J, Narayana A, Wolden S, Hunt M, Stambuk H, Pfister D, Kraus D, Shaha A, Shah J, Lee NY.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):363-73. PubMed ID: 15925451
    [Abstract] [Full Text] [Related]

  • 6. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA.
    Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):1-8. PubMed ID: 19111400
    [Abstract] [Full Text] [Related]

  • 7. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
    Biagioli MC, Harvey M, Roman E, Raez LE, Wolfson AH, Mutyala S, Han HS, Markoe A.
    Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1067-73. PubMed ID: 17967302
    [Abstract] [Full Text] [Related]

  • 8. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R, Sonis S, Posner M, Wirth L, Costello R, Braschayko P, Allen A, Mahadevan A, Flynn J, Burke E, Li Y, Tishler RB.
    Cancer; 2009 Oct 01; 115(19):4514-23. PubMed ID: 19634161
    [Abstract] [Full Text] [Related]

  • 9. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1440-50. PubMed ID: 15590175
    [Abstract] [Full Text] [Related]

  • 10. Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma.
    Lee SW, Back GM, Yi BY, Choi EK, Ahn SD, Shin SS, Kim JH, Kim SY, Lee BJ, Nam SY, Choi SH, Kim SB, Park JH, Lee KK, Park SH, Kim JH.
    Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):152-60. PubMed ID: 16472934
    [Abstract] [Full Text] [Related]

  • 11. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    McCloskey SA, Jaggernauth W, Rigual NR, Hicks WL, Popat SR, Sullivan M, Mashtare TL, Khan MK, Loree TR, Singh AK.
    Am J Clin Oncol; 2009 Dec 01; 32(6):587-91. PubMed ID: 19581794
    [Abstract] [Full Text] [Related]

  • 12. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.
    Studer G, Huguenin PU, Davis JB, Kunz G, Lütolf UM, Glanzmann C.
    Radiat Oncol; 2006 Mar 31; 1():7. PubMed ID: 16722599
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
    Budach V, Stuschke M, Budach W, Baumann M, Geismar D, Grabenbauer G, Lammert I, Jahnke K, Stueben G, Herrmann T, Bamberg M, Wust P, Hinkelbein W, Wernecke KD.
    J Clin Oncol; 2005 Feb 20; 23(6):1125-35. PubMed ID: 15718308
    [Abstract] [Full Text] [Related]

  • 15. Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
    Milano MT, Vokes EE, Kao J, Jackson W, List MA, Stenson KM, Witt ME, Dekker A, MacCracken E, Garofalo MC, Chmura SJ, Weichselbaum RR, Haraf DJ.
    Int J Oncol; 2006 May 20; 28(5):1141-51. PubMed ID: 16596230
    [Abstract] [Full Text] [Related]

  • 16. Acute toxicities experienced during simultaneous integrated boost intensity-modulated radiotherapy in head and neck cancers--experience from a north Indian regional cancer centre.
    Chakraborty S, Ghoshal S, Patil V, Oinam A, Suresh S.
    Clin Oncol (R Coll Radiol); 2009 Nov 20; 21(9):676-86. PubMed ID: 19748768
    [Abstract] [Full Text] [Related]

  • 17. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
    Kim K, Wu HG, Kim HJ, Sung MW, Kim KH, Lee SH, Heo DS, Kim HJ, Park CI.
    Head Neck; 2009 Sep 20; 31(9):1121-8. PubMed ID: 19340863
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P, Putnik K, Kreimeyer T, Sprague LD, Koelbl O, Schäfer C.
    BMC Cancer; 2006 Dec 07; 6():279. PubMed ID: 17150114
    [Abstract] [Full Text] [Related]

  • 20. Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience.
    Allal AS, Taussky D, Mach N, Becker M, Bieri S, Dulguerov P.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1431-6. PubMed ID: 15050320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.